Results 231 to 240 of about 38,575 (307)
Acute Systemic Complications Following High‐Dose Semaglutide Reinitiation in an Elderly Patient
ABSTRACT Severe gastrointestinal intolerance with systemic complications can occur within hours of reinitiating high‐dose semaglutide after a prolonged treatment interruption, even in patients who previously tolerated the medication. Elderly patients with comorbidities may be particularly vulnerable.
Jay Mehta, Brent Tai, Johnathan Frunzi
wiley +1 more source
Intraoperative Endoluminal Pyloromyotomy Versus Stretching of the Pylorus for the Reduction of Delayed Gastric Emptying After Pylorus-Preserving Partial Pancreatoduodenectomy: A Blinded Randomized Controlled Trial (PORRIDGE Study; DRKS00013503). [PDF]
Schrempf MC +9 more
europepmc +1 more source
Immediate Remote Common Femoral Artery Rupture After Vascular Closure Device Deployment
ABSTRACT Vascular closure devices may cause life‐threatening femoral artery rupture remote from the puncture site. Sudden hemodynamic instability after device deployment should prompt immediate evaluation for proximal arterial injury, even when femoral access appears technically successful.
Junghyun Park, Jeffrey Steinberg
wiley +1 more source
As antiretroviral therapy (ART) prolongs lifespans, people with HIV (PWH) face a new syndemic: Cardiovascular‐Kidney‐Metabolic (CKM) syndrome. Yet CKM in PWH is poorly characterized. Inflammation, complex pharmacokinetic (PK) alterations, ART‐associated metabolic effects, and gut dysbiosis amplify risk. Managing CKM increases medication burden, thereby
Aaron S. Devanathan, Thomas D. Nolin
wiley +1 more source
Signals arising from the gastrointestinal tract that affect food intake (Syömiseen vaikuttavat mahasuolikanavan signaalit) [PDF]
Purhonen, Anna-Kaisa
core
The effect of resveratrol on cognitive performance: a systematic literature review and meta-analysis [PDF]
Annois, Brigitte +7 more
core
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott +7 more
wiley +1 more source
ABSTRACT Aims Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are widely used for metabolic disorders, but emerging safety concerns include alopecia and reproductive or endocrine‐related adverse events (AEs). This study investigated the association between specific GLP‐1 RAs and these endocrine‐related AEs using a large‐scale pharmacovigilance ...
Nai Lee, Yun Kim
wiley +1 more source

